Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European Union – Padovanews padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.
Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by EMA to the European Committee (EC), the EC has granted Marketing Authorisation to Bracco Imaging for its Vueway (gadopiclenol) contrast agent in the European Union
/PRNewswire/ Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced today its schedule of activities at the.
/PRNewswire/ Riboscience, LLC, today announced the first presentation of data from the ongoing Phase 1 clinical trial of the ENPP1 inhibitor RBS2418 that.
Vueway® (Gadopiclenol) Receives Positive CHMP Opinion – Padovanews padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.